Scarica l'app Stockscreener
4.635
10.62%
-0.545
Dopo l'orario di chiusura:
4.63
-0.005
-0.11%
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN
Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia
Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com
Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks
Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat
Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria
Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa
Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria
Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com
Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times
Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative
Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan
Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn
Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets
BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN
Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat
Is Organogenesis Holdings Inc. stock dividend yield sustainableJuly 2025 Outlook & Breakout Confirmation Trade Signals - DonanımHaber
Is Organogenesis Holdings Inc. stock supported by strong cash flows2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Organogenesis (NASDAQ:ORGO) Director Glenn Nussdorf Sells 200,000 Shares - MarketBeat
Organogenesis Holdings Insider Sold Shares Worth $1,027,060, According to a Recent SEC Filing - marketscreener.com
Organogenesis Holdings Inc. (ORGO) director sells 200,000 shares - Stock Titan
How Organogenesis Holdings Inc. stock benefits from global expansion2025 Big Picture & Low Risk High Win Rate Stock Picks - Улправда
Organogenesis (NASDAQ:ORGO) Trading Up 8.5%Here's What Happened - MarketBeat
How Organogenesis Holdings Inc. stock reacts to oil pricesBreakout Watch & Consistent Return Strategy Ideas - Улправда
Recent Analysts’ Ratings Updates for Organogenesis (ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Earns “Buy” Rating from BTIG Research - Defense World
Organogenesis (NASDAQ:ORGO) Shares Gap UpTime to Buy? - MarketBeat
BTIG Research Reaffirms Buy Rating for Organogenesis (NASDAQ:ORGO) - MarketBeat
Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell - marketscreener.com
Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times
Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com Nigeria
Organogenesis to submit rolling BLA for knee osteoarthritis treatment - Investing.com India
Organogenesis to submit rolling BLA for knee osteoarthritis treatment By Investing.com - Investing.com Australia
Organogenesis announces successful FDA meeting and plan to file BLA for ReNu® - marketscreener.com
Organogenesis (Nasdaq: ORGO) to file BLA for ReNu knee OA pain by Dec. 2025 - Stock Titan
December 2025's Top Penny Stocks With Promising Potential - simplywall.st
Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) - Seeking Alpha
Investors in cash trouble should check out Organogenesis Holdings Inc (ORGO) - setenews.com
Why analysts remain bullish on Organogenesis Holdings Inc. stockEarnings Beat & Technical Entry and Exit Alerts - Newser
Is Organogenesis Holdings Inc. stock attractive for income investorsMarket Movers & Technical Buy Zone Confirmation - Newser
2.19%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):